UC San Diego professor Ludmil Alexandrov will lead an international team of scientists awarded $25 million to research cancer mutations. The award comes from Cancer Grand Challenges, a collaboration ...

Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.

The FDA has faced an extraordinary convergence of political, scientific, legal, and operational pressures over the last year.

The study found that low- and middle-income nations are more affected by breast cancer cases in comparison to high-income groups. To know what are some of the leading causes of breast cancer, read on.

Critically ill two-year-old Oli-Jay Morris suffers from a gene mutation that is completely unique to him - but his family ...

For decades, breast cancer was widely associated with women over the age of 50. Today, that assumption is quietly changing. Hospitals across India and globally are seeing more women in their late 20s ...

A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...

New findings show how inherited and acquired genetic mutations cause breast cancer resistance to CDK4/6 inhibitors.

The Commissioner’s National Priority Voucher pilot program enabled rolling review, enhanced FDA interaction, and a rapid 44-day decision, alongside breakthrough therapy and priority review ...

Drug Farm today announced that the U.S. Food and Drug Administration (U.S. Food and Drug Administration, FDA) has accepted DF ...

My journey has been a long one. I am a paediatric immunologist and principal investigator of a PID research laboratory, and ...